Skip to main content
. 2022 Aug 19;127(9):1701–1708. doi: 10.1038/s41416-022-01932-1

Fig. 3. Flowchart of the patients sequenced within the LCCH umbrella.

Fig. 3

Finally, a molecular target was available in 38 out of 47 patients, from which 19 received a molecular-matched drug treatment.